Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News VolitionRX Ltd VNRX

Healthcare Medical Instruments & Supplies
VolitionRx Limited is a multi-national epigenetics company focused on advancing the science of epigenetics. The Company is dedicated to saving lives and improving outcomes for people and animals with life-altering diseases through earlier detection, as well as disease and treatment monitoring. Through its subsidiaries, it is developing and commercializing blood tests to help diagnose and... see more

Recent & Breaking News (NYSEAM:VNRX)

Volition Develops a New Improved Nu.Q(TM) Assay Format

PR Newswire January 13, 2020

VolitionRx Completes Acquisition of Octamer GmbH

PR Newswire January 10, 2020

VolitionRx Limited Announces Strategic Acquisition

PR Newswire December 16, 2019

VolitionRx and Gyros Protein Technologies Awarded an Aggregate $1 million+ Eurostars Cash Grant to Collaborate on Developing a Lung Cancer Blood Test

PR Newswire December 5, 2019

VolitionRx Limited Announces Proof of Concept Data in Lymphoma and Leukemia

PR Newswire December 3, 2019

VolitionRx Limited Announces Third Quarter 2019 Financial Results and Business Update

PR Newswire November 12, 2019

VolitionRx Limited Schedules Third Quarter 2019 Earnings Conference Call and Business Update

PR Newswire November 7, 2019

Volition announces $500,000 in Non-Dilutive Funding for Volition Veterinary and issues Video

PR Newswire October 29, 2019

Texas A&M University Takes A 12.5% Equity Stake in Volition Veterinary Diagnostics Development LLC

PR Newswire October 25, 2019

Nu.Q(TM) Vet Pre-Analytical Data to be Presented at the Veterinary Cancer Society Annual Conference in Houston, Texas

PR Newswire October 18, 2019

Volition Appoints Dr. Phillip Barnes to Board of Directors

PR Newswire October 9, 2019

VolitionRx Limited Announces Second Quarter 2019 Financial Results and Business Update

PR Newswire August 12, 2019

Volition Forms Texas-Based Veterinary Subsidiary and Appoints its Chief Executive Officer

PR Newswire August 8, 2019

VolitionRx Limited Schedules Second Quarter 2019 Earnings Conference Call and Business Update

PR Newswire August 7, 2019

Volition Announces Exercise of Warrant to Purchase $4.8 Million in Common Stock

PR Newswire July 24, 2019

VolitionRx Limited Commences Lung Cancer Clinical Study with Fosun Long March in China

PR Newswire July 18, 2019

VolitionRx Limited Awarded an Additional $1.4 Million in Non-Dilutive Funding

PR Newswire July 10, 2019

VolitionRx Limited Announces First Quarter 2019 Financial Results and Business Update

PR Newswire May 8, 2019

VolitionRx Limited Executes a Contract for Clinical Trial Program in Lung Cancer

PR Newswire May 7, 2019

VolitionRx Limited Schedules First Quarter 2019 Earnings Conference Call and Business Update

PR Newswire May 6, 2019